Searchable abstracts of presentations at key conferences in endocrinology

ea0038oc2.6 | Translational pathophysiology and therapeutics | SFEBES2015

Treatment with the epigenetic modifying compound JQ1+ can significantly reduce the proliferation of pancreatic neuroendocrine tumours in a mouse model of multiple endocrine neoplasia type 1

Lines Kate E , Stevenson Mark , Filippakopoulos Panagis , Muller Susanne , Knapp Stefan , Bountra Chas , Thakker Rajesh V

There are currently no curative treatments for metastatic pancreatic neuroendocrine tumours (PNETs), and the 5-year survival is <50%. Such tumours frequently have mutations in chromatin remodelling genes as well as the protein encoded by the multiple endocrine neoplasia type 1 (MEN1) gene, menin, which is mutated in up to 40% of sporadic PNETs, and binds the histone methyltransferase MLL1. Histone modifications, and specifically acetylated residues on histone tail...

ea0037ep1125 | Endocrine tumours | ECE2015

Mitotane directly interacts with lipid membranes and alters membrane structure and dynamics

Muller Peter , Theisgen Stephan , Schirbel Andreas , Sbiera Silviu , Haralampiev Ivan , Fassnacht Martin , Huster Daniel , Kroiss Matthias

Context: Mitotane (1,1-dichloro-2-[o-chlorophenyl]-2-[p-chlorophenyl]ethane) is the only drug approved for treatment of adrenocortical carcinoma (ACC). Mitotane counteracts both tumor growth and tumoural steroid hormone production but treatment is severely hampered by unfavorable pharmacokinetics and serious side effects. Mitotane is a lipophilic compound and treatment emergent alterations of lipid metabolism are frequently observed. This raises the question whether mitotane d...

ea0032p766 | Obesity | ECE2013

No long-term weight reduction after gastric banding (LAGB) in obese patients with craniopharyngioma involving hypothalamic structures: experiences from KRANIOPHARYNGEOM 2000

Sterkenburg Anthe , Gebhardt Ursel , Hioffmann Anika , Maroske Jorn , Hanisch Ernst , Muller Hermann

Background: Craniopharyngiomas are embryogenic malformations which lead to eating disorders and morbid obesity due to hypothalamic involvement. The experience with laparoscopic adjustable gastric banding (LAGB) in obese craniopharyngioma patients is limited especially in regard to long-term effects and tolerability.Patients and methods: We are reporting on four patients with childhood craniopharyngioma diagnosed at age 2, 13, 12, and 20 years.<p clas...

ea0031s9.3 | Novel aspects of GPCR signalling (Supported by the <emphasis role="italic">Journal of Endocrinology</emphasis>) | SFEBES2013

In vivo dimerization of LH receptors

Rivero-Muller Adolfo , Jonas Kim , Trehan Ashutosh , Hanyaloglu Aylin , Huhtaniemi Ilpo

The classical model of GPCR activation entails the binding of a single ligand to a single receptor molecule, followed by transmembrane signal transduction to the appropriate G protein(s). The possibility of GPCRs functioning as dimers or oligomers still remains controversial, and is largely based on in vitro studies on transfected cells. The glycoprotein hormone receptors, including that of LH (LHCGR), differ from most GPCRs by their large extracellular ligand-binding...

ea0031oc3.3 | Reproduction, growth and development | SFEBES2013

Regulation of G protein-coupling specificity via cis and trans activation of the LH/chorionic gonadotrophin receptor (LHCGR)

Jonas Kim , Muller Adolfo Rivero , Chou Yen Yin , Ji Tae , Hanyaloglu Aylin

Accepted dogma once stated that G protein-coupled receptors (GPCRs) function as monomers, however, over the last decade in vitro experiments have shown GPCRs to function as dimers and higher order oligomers. We have recently reported the first in vivo evidence for the physiological importance of Class A GPCR homodimerisation using the LHCGR as a model receptor. Transgenic co-expression of binding deficient LHCGR (LHCGR-LH) and signalling deficient ...

ea0029oc1.5 | Pituitary Clinical I | ICEECE2012

Initial hypothalamic involvement is the major risk factor for impaired prognosis and quality of life in childhood craniopharyngioma regardless of chosen treatment strategies: results of KRANIOPHARYNGEOM 2000

Muller H. , Gebhardt U. , Warmuth-Metz M. , Kortmann R. , Faldum A. , Pietsch T. , Gabriele C. , Sorensen N.

Hypothalamic obesity has major impact on prognosis and quality of life (QoL) in childhood craniopharyngioma (CP). The pathogenic relevance of initial hypothalamic involvement versus treatment-related hypothalamic lesions is a matter of controversy.One hundred and twenty patients were recruited prospectively during 2001 and 2007 and evaluated after 3 years of follow-up. Body mass index (BMI) and QoL at diagnosis and 36 mo after diagnosis were analyzed bas...

ea0029p1173 | Obesity | ICEECE2012

Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects

Schulte D. , Muller N. , Neumann K. , Oberhauser F. , Faust M. , Gudelhofer H. , Krone W. , Laudes M.

Background: Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes on the other site are able to release the specific wnt5a inhibitor sFRP5. This protective effect, however, was found to be diminished in obesity. The aim of the present study was to examine i) whether obese human subjects exhibit increased serum concentrations...

ea0029p1244 | Obesity | ICEECE2012

Changes of peripheral α-melanocortin stimulating hormone (α-MSH) in childhood craniopharyngioma patients in comparison with other forms of childhood obesity

Muller H. , Enriori P. , Gebhardt U. , Hinney A. , Hebebrandt J. , Reinehr T. , Cowley M. , Roth C.

Objective: Relationships of blood circulating melanocortins to childhood obesity are not well established. We evaluated serum α-melanocyte stimulating hormone (α-MSH) in lean children and different study groups of childhood obesity.Methods: We examined serum α-MSH in 52 otherwise healthy children with childhood obesity (Ob, mean age 11 years, 32 girls / 20 boys), 27 normal-weight children of same age, 7 additional obese patients with reduc...

ea0029p1307 | Paediatric endocrinology | ICEECE2012

Randomized multicenter trial on patients with childhood craniopharyngioma (KRANIOPHARYNGEOM 2007): update after 49 months of recruitment

Muller H. , Gebhardt U. , Kortmann R. , Warmuth-Metz M. , Faldum A. , Pietsch T. , Sorensen N. , Calaminus G.

Despite high survival rates (92%) in patients with childhood craniopharyngioma (CP), quality of life (QoL) is frequently impaired due to sequelae such as severe obesity resulting from hypothalamic involvement of CP. Based on the results of the multicenter prospective study KRANIOPHARYNGEOM 2000 radical surgery is no appropriate treatment strategy in patients with hypothalamic involvement. Furthermore, tumour progression/relapses are frequent early events in CP patients. The an...

ea0028p279 | Reproduction | SFEBES2012

Dimerisation of luteinising hormone/chorionic gonadotrophin receptor (LHCGR); impact on intracellular signaling responses and ligand specificity

Jonas Kim , Rivero-Muller Adolfo , Chou Yen-Yin , Ji Tae , Hanyaloglu Aylin , Huhtaniemi Ilpo

G protein-coupled receptors (GPCRs) are one of the largest families of the mammalian genome, mediating the effects of approximately 40% of prescribed drugs. Until recently, accepted dogma stated that GPCRs exist as monomers, however, it is becoming evident that GPCRs can form higher order dimer/oligomer complexes which provide important mechanisms for the diversification of receptor function. The LHCGR is a class A family GPCR, primarily coupling to the Gαs pat...